Warning on Compounded GLP-1s; Ketoacidosis Deaths; Axon Stim for Diabetic Nerve Pain
(MedPage Today) -- The Obesity Society, Obesity Action Coalition, and Obesity Medicine Association released a joint statement warning against the use of compounded GLP-1 receptor agonists.
Novo Nordisk resumed shipments of its 1.7-mg dose of semaglutide...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news
More News: Diabetes | Eating Disorders & Weight Management | Endocrinology | Obesity | Pain | Warnings